Q4 2025 Holdings
Filed 2026-02-17 | 116 holdings | $5.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $100.1M | 8,284,882 | 1.8% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $100.5M | 3,069,225 | 1.8% |
| Immatics N.v(IMTX) | SHS | N44445109 | $109.0M | 10,383,456 | 1.9% |
| Edgewise Therapeutics(EWTX) | COM | 28036F105 | $110.6M | 4,457,974 | 2.0% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $114.8M | 1,452,707 | 2.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $117.9M | 1,350,425 | 2.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $121.9M | 1,200,487 | 2.2% |
| Spdr Series Trust(XBI)Put | STATE STREET SPD | 78464A870 | $134.1M | 1,100,000 | 2.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $163.5M | 4,278,180 | 2.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $167.5M | 1,665,105 | 3.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $173.3M | 7,985,461 | 3.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $175.9M | 2,330,651 | 3.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $230.6M | 1,081,421 | 4.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $272.6M | 2,546,391 | 4.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $315.2M | 3,160,200 | 5.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $588.3M | 1,995,986 | 10.5% |